Letter: Risks and benefits of hormonal agents in pregnancy.
D000818:Animals; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects*; D012739:Gonadal Steroid Hormones / Q000009:adverse effects*; D006801:Humans; D006908:Hydroxyprogesterones / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008431:Maternal-Fetal Exchange; D051379:Mice; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D011247:Pregnancy; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014625:Vaginal Neoplasms / Q000139:chemically induced
D012739:Gonadal Steroid Hormones; D006908:Hydroxyprogesterones; D004054:Diethylstilbestrol